Post-approval studies (Phase 4)Study completedNCT05154383
What this trial is testing
Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression
Who this might be right for
Vaccine Reaction
Centre Hospitalier Annecy Genevois 60